Metabolism of nifedipine by placental CYP19A1 and competitive inhibition by chlorpromazine

This publication has 41 references indexed in Scilit:

• Use of physiologically‐based pharmacokinetic modeling to understand the effect of omeprazole administration on the pharmacokinetics of oral extended‐release nifedipine
  CPT: Pharmacometrics & Systems Pharmacology, 2023
• The role of CYP1A1/2 in cholesterol ester accumulation provides a new perspective for the treatment of hypercholesterolemia
  Acta Pharmaceutica Sinica B, 2022
• The etiology of preeclampsia
  American Journal of Obstetrics and Gynecology, 2022
• An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array
  American Journal of Obstetrics and Gynecology, 2022
• Eclampsia in the 21st century
  American Journal of Obstetrics and Gynecology, 2022
• Nifedipine disturbs fetal cardiac function during hypoxemia in a chronic sheep model at near term gestation
  American Journal of Obstetrics and Gynecology, 2021
• Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis
  American Journal of Obstetrics and Gynecology, 2020
• A novel GC-MS methodology to evaluate aromatase activity in human placental microsomes: a comparative study with the standard radiometric assay
  Analytical and Bioanalytical Chemistry, 2019
• The effects of nifedipine and ivabradine on the functionality of the early rat embryonic heart. Are these drugs a risk in early human pregnancy?
  Birth Defects Research, 2019
• Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta
  Acta Histochemica, 2018